Stryker Corporation (SYK)
Last Price$371.1(0.8%)
Market Cap$141.4B
SYK Rating
SYK Quality rating performance
SYK Intrinsic Value
Key Highlights:
As of Mar 21, 2025 SYK Relative Value is $304.9, which is overvalued by 17.8%, compared to current share price of $371.1.
As of Mar 21, 2025 SYK DCF Value is $307.0, which is overvalued by 17.3%, compared to current share price of $371.1.
SYK Share Price History
1W 0.4%
1M (3.0%)
6M 1.7%
YTD 26.4%
1Y 5.9%
3Y 44.2%
5Y 209.9%
10Y 345.6%
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
Crunching data... Almost there!
SYK Stock Metrics
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Base
$141.4B
$150.6B
$22.6B
$3,487.0M
Shares Outstanding
381M
Employees
53K
Growth (CAGR)
8.7%
7.13%
17.7%
71.25%
Profitability
62.8%
16.8%
13.2%
18.8%
15.4%
116.5%
Intrinsic Value
$305.8 (17.6% overvalued)
$306.8
$304.8
$302.1
$527.5
27.2%
Return on Capital
Financial Health
$4,402.0M
$9,195.0M
2.6x
65.9%
Dividends
10.2%
0.9%
35.0%
Mar 31, 2025
Earnings
Jul 28, 2025
BEAT by 1.2%
BEAT by 3.5%
45.3%
9 Beat & 1 Miss
SYK Stock Financials
SYK Income Statement Metrics
Annual
Quarterly
LTM
SYK Cash Flow Statement Metrics
Annual
Quarterly
LTM
Operating Cash Flow (OCF)
$4,242.0M +14.3% YoY
Capital Expenditure (CAPEX)
($755.0M) +31.3% YoY
Free Cash Flow (FCF)
$3,487.0M +11.2% YoY
SYK Income Statement Overview
Annual
Quarterly
LTM
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Dec'24
$22.6B 10.2% YoY
Cost of revenue
$8,155.0M 10.2% YoY
Pre-tax income
$3,492.0M (4.9%) YoY
15.5% margin
SYK Balance Sheet Overview
Annual
Quarterly
LTM
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Dec'24
Assets
Liabilities
Total assets
$43.0B
Current assets ($14.8B, 34.6% of total)
$4,402.0M (10.2%)
$3,987.0M (9.3%)
Other current assets
$6,458.0M (15.0%)
Non-current assets ($28.1B, 65.4% of total)
$0.0 (0.0%)
$3,448.0M (8.0%)
$4,395.0M (10.2%)
Other non-current assets
$20.3B (47.2%)
Financial position
($2,993.0M)
Cash & Short-term
Investments
Total Debt
SYK Stock Ratios
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
SYK Earnings Surprises
Crunching data... Almost there!
SYK Dividends
SYK Dividend Yield
Crunching data... Almost there!
SYK Dividend Per Share
3Y
10Y
30Y
Annual
Quarterly
LTM
Competing with SYK
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$141.4B | 6.7 | $305.8 17.6% overvalued | 5.9% | $22.6B | $3,487.0M | 10.2% | 15.4% | 62.8% | 10.4% | 65.9% | |
$218.8B | 7.1 | $187.7 48.6% undervalued | 15.6% | $42.0B | $6,351.0M | 4.6% | 15.1% | 55.6% | 25.3% | 31.4% | |
$148.2B | 6.8 | $37.4 62.9% overvalued | 49.0% | $16.7B | $2,438.0M | 17.6% | 14.6% | 67.0% | 8.0% | 50.7% | |
$115.8B | 6.4 | $122.4 35.5% undervalued | 11.1% | $33.2B | $5,467.0M | 2.7% | 16.5% | 62.9% | 7.4% | 53.6% | |
$41.6B | 6.1 | $56.4 20.0% overvalued | (25.6%) | $5,724.3M | $289.9M | (4.7%) | 5.1% | 78.4% | 21.6% | 7.0% | |
$29.5B | 7.3 | $40.2 45.6% overvalued | (44.7%) | $4,033.0M | $630.7M | 11.3% | 15.6% | 60.4% | 21.7% | 120.3% | |
$23.6B | 5.3 | $72.8 185.6% undervalued | 29.4% | €18.0B | €1,145.0M | (0.8%) | 6.4% | 43.1% | (4.2%) | 63.4% | |
$22.4B | 5.8 | $185.6 67.6% undervalued | (12.1%) | $7,678.6M | $1,132.4M | 3.8% | 14.7% | 66.0% | 6.3% | 43.0% | |
$21.7B | 6.4 | $204.3 7.3% overvalued | (2.0%) | $5,398.4M | $751.4M | (0.2%) | 13.9% | 44.7% | 8.2% | 35.6% | |
$18.8B | 7.9 | $107.4 60.0% overvalued | 61.0% | $1,900.3M | $303.0M | 12.0% | 15.9% | 76.4% | 26.9% | 6.9% | |
$12.5B | 7.9 | $153.5 54.2% overvalued | 21.2% | $788.0M | $166.1M | 41.4% | 21.1% | 87.0% | 31.2% | 103.3% |
FAQ
What is Stryker Corporation (SYK) stock rating?
As of today, Stryker Corporation has a stock rating of 7 (out of 10), which is considered Good.
is Stryker Corporation (SYK) a good stock to buy?
As of today, Stryker Corporation has a Good stock rating, which is 17.6% overvalued. According to Value Sense backtesting, stocks with similar profile tend to underperform the market by 4.6%.